Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

Acute myeloid leukemia is one of the deadliest cancers. Leukemic stem cells responsible for the disease are highly resistant to treatment. A new editorial paper was published in Oncotarget's ...

A new classification model called AML60+ improved risk stratification for older adults with acute myeloid leukemia, which can improve clinical decision making. A new risk stratification system aims to ...

Acute myeloid leukemia (AML) is a blood cell cancer that is estimated to cause ∼100,000 deaths worldwide each year. (1) Current standard of care includes treatment with chemotherapeutic agents, newer ...

This paper introduces a novel lightweight YOLOv8 model, integrated with a residual attention mechanism, to improve leukemia detection and classification. The enhancements to the YOLOv8n architecture ...

Oct 21 (Reuters) - Former Hollywood producer Harvey Weinstein has chronic myeloid leukemia (CML), NBC News reported on Monday, citing sources. Weinstein is currently undergoing treatment for CML ...

1 A paper by Cronkite 2 (1961) summarizes the natural history of "benzene leukemia ... chromosomes of the first two groups of the Denver classification gave evidence of deletions; polyploidism ...

However, it is hard to identify the disease stage from symptoms alone. Early symptoms that occur with acute forms of leukemia, like ALL or AML, can begin and intensify suddenly over a matter of days ...